Inventor · disambiguated record
Mark Mclaughlin
Also filed as: MCLAUGHLIN MARK · MCLAUGHLIN MARK L · MCLAUGHLIN MARK LEE
28 granted patents·19 pending applications·186 citations·filing 1990–2025
95Inventor score
Files withH LEE MOFFITT CANCER CT & RES25MERCK SHARP & DOHME5UNIV LOUISIANA STATE4UNIV SOUTH FLORIDA3LINGHU XIN2
Top patents by PatentIndex Score
47 records- 0188US8853149B2Integrin interaction inhibitors for the treatment of cancerHAZLEHURST LORI·Filed 2011·Granted Oct 7, 2014·18 cites·102 claims
- 0288US5789542AAmphipathic peptidesUNIV LOUISIANA STATE·Filed 1997·Granted Aug 4, 1998·110 cites·32 claims
- 0387US10118942B2Toll-like receptor 2 ligands and methods of making and using thereofH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Nov 6, 2018·4 cites·12 claims
- 0483US10793595B2Toll-like receptor 2 ligands and methods of making and using thereofH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Oct 6, 2020·2 cites·12 claims
- 0583US10011635B2Cyclic peptide conjugates and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2014·Granted Jul 3, 2018·3 cites·9 claims
- 0682US10449227B2Conjugates for immunotherapyH LEE MOFFITT CANCER CT & RES·Filed 2015·Granted Oct 22, 2019·2 cites·9 claims
- 0780US12186404B2Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancerH LEE MOFFITT CANCER CT & RES·Filed 2022·Granted Jan 7, 2025·0 cites·6 claims
- 0879US11078235B2Cyclic peptide conjugates and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Aug 3, 2021·1 cites·3 claims
- 0979US10059740B2Integrin interaction inhibitors for the treatment of cancerH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Aug 28, 2018·2 cites·16 claims
- 1078US12291724B2Tumor-infiltrating lymphocytes for adoptive cell therapyH LEE MOFFITT CANCER CT & RES·Filed 2022·Granted May 6, 2025·0 cites·25 claims
- 1177US12508329B2Radiotherapeutic and companion imaging agents to target MC1RH LEE MOFFITT CANCER CT & RES·Filed 2022·Granted Dec 30, 2025·0 cites·19 claims
- 1273US6566334B1Short amphipathic peptides with activity against bacteria and intracellular pathogensUNIV LOUISIANA STATE·Filed 1998·Granted May 20, 2003·32 cites·39 claims
- 1372US2025367312A1Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancerH LEE MOFFITT CANCER CENTER AND RES INSTITUTE·Filed 2025·Application pending·0 cites
- 1471US9409927B2Super lewis acidic borate esters as 18F-labeled PET probesUNIV SOUTH FLORIDA·Filed 2014·Granted Aug 9, 2016·1 cites·11 claims
- 1571US2024041972A1Conjugates for immunotherapyH LEE MOFFITT CANCER CT & RES·Filed 2023·Application pending·0 cites
- 1670US11406723B2Radiotherapeutic and companion imaging agents to target MC1RH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Aug 9, 2022·0 cites·12 claims
- 1770US2020197530A1Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancerH LEE MOFFITT CANCER CT & RES·Filed 2019·Application pending·0 cites
- 1868US11518980B2Tumor-infiltrating lymphocytes for adoptive cell therapyH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Dec 6, 2022·0 cites·22 claims
- 1968US11414455B2Toll-like receptor 2 ligands and methods of making and using thereofH LEE MOFFITT CANCER CT & RES·Filed 2020·Granted Aug 16, 2022·0 cites·10 claims
- 2068US2025136642A1Cyclic peptide compounds and methods of use thereofMODULATION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2164US12060438B2Cyclic peptide compounds and methods of use thereofMODULATION THERAPEUTICS INC·Filed 2019·Granted Aug 13, 2024·0 cites·4 claims
- 2264US2024189441A1A delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancerWEST VIRGINIA UNIV BOARD OF GOVERNORS ON BEHALF OF WEST VIRGINIA UNIV·Filed 2022·Application pending·0 cites
- 2362US10556928B2Stabilized peptoid-peptide hybrids and uses thereofH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Feb 11, 2020·0 cites·12 claims
- 2462US10426843B2Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancerH LEE MOFFITT CANCER CT & RES·Filed 2017·Granted Oct 1, 2019·0 cites·12 claims
- 2562US2024181095A1A delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancerWEST VIRGINIA UNIV BOARD OF GOVERNORS ON BEHALF OF WEST VIRGINIA UNIV·Filed 2022·Application pending·0 cites
- 2660US2015017259A1Integrin interaction inhibitors for the treatment of cancerH LEE MOFFITT CANCER CT & RES·Filed 2014·Application pending·0 cites
- 2760US2021154221A14'-substituted nucleoside reverse transcriptase inhibitors and preparations thereofMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 2859US2018362583A1Integrin interaction inhibitors for the treatment of cancerH LEE MOFFITT CANCER CT & RES·Filed 2018·Application pending·0 cites
- 2958US2020188472A1Conjugates for immunotherapyH LEE MOFFITT CANCER CT & RES·Filed 2019·Application pending·0 cites
- 3057US11123435B2TLR9 targeted therapeuticsH LEE MOFFITT CANCER CT & RES·Filed 2017·Granted Sep 21, 2021·0 cites·5 claims
- 3155US2018126013A1Radiotherapeutic and companion imaging agents to target mc1rH LEE MOFFITT CANCER CT & RES·Filed 2016·Application pending·0 cites
- 3253US10197575B2Stabilized peptoid-peptide hybrids and uses thereofH LEE MOFFITT CANCER CT & RES·Filed 2015·Granted Feb 5, 2019·0 cites·16 claims
- 3353US10053466B2Process for preparing chiral dipeptidyl peptidase-IV inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Aug 21, 2018·0 cites·5 claims
- 3452US2010216992A1Mimetic compositions and the production thereofUNIV SOUTH FLORIDA·Filed 2008·Application pending·0 cites
- 3551US7345022B2Anti-fibril peptidesUNIV LOUISIANA STATE·Filed 2003·Granted Mar 18, 2008·0 cites·24 claims
- 3651US7262163B2Short amphipathic peptides with activity against bacteria and intracellular pathogensUNIV LOUISIANA STATE·Filed 2003·Granted Aug 28, 2007·8 cites·40 claims
- 3750US2014322227A1Peptides for treatment of bone deficiency and autoimmune disordersH LEE MOFFITT CANCER CT & RES·Filed 2014·Application pending·0 cites
- 3849US2015105328A1Peptoid-peptide hybrids and their useUNIV SOUTH FLORIDA·Filed 2014·Application pending·0 cites
- 3947US2009176986A1Process for the Preparation of Pyridine Heterocycle Cgrp Antagonist IntermediateMCLAUGHLIN MARK·Filed 2007·Application pending·0 cites
- 4047US2015071918A1Peptides for the treatment of cancerH LEE MOFFITT CANCER CT & RES·Filed 2013·Application pending·0 cites
- 4145US9862725B2Process for preparing chiral dipeptidyl peptidase-IV inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jan 9, 2018·0 cites·7 claims
- 4245US2017081635A1Tumor-infiltrating lymphocytes for adoptive cell therapyH LEE MOFFITT CANCER CT & RES·Filed 2015·Application pending·0 cites
- 4344US5068469AProcess for preparation of condensed alcohols by alkoxide catalystsEXXON CHEMICAL PATENTS INC·Filed 1990·Granted Nov 26, 1991·3 cites·5 claims
- 4437US10392353B2Processes for making substituted quinazoline compounds using hydrogen bonding catalystsMERCK SHARP & DOHME·Filed 2016·Granted Aug 27, 2019·0 cites·17 claims
- 4535US2010234604A1Process for Making Substituted Aryl Sulfone IntermediatesLINGHU XIN·Filed 2010·Application pending·0 cites
- 4635US2010234603A1Process for Making Substituted Aryl Sulfone IntermediatesLINGHU XIN·Filed 2010·Application pending·0 cites
- 4733US10131674B2Process for preparing Substituted Indole CompoundsMERCK SHARP & DOHME·Filed 2015·Granted Nov 20, 2018·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →